SCHEMBL2010866

SCHEMBL2010866

O=[C]c1cn[nH]c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4497205 0.74
SCHEMBL20578549 0.74 KCNH2 (0.40)
SCHEMBL9998552 0.74
SCHEMBL31504928 0.72 HAO1 (0.49)
Hydrochloric Acid SCHEMBL2450441 0.72
SCHEMBL20409158 0.70
SCHEMBL8309544 0.69
SCHEMBL461868 0.67 KCNH2 (0.39)
SCHEMBL527210 0.67 APP (0.52)
SCHEMBL19303487 0.66 KCNH2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3558980-B1 COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION C N C C S S C A R L COLLEZIONE NAZ DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) 2021-01-27 EP claimed
EP-3749666-A1 HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2020-12-16 EP claimed
US-20200383984-A1 HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2020-12-10 US claimed
CN-111971280-A Heteroaryl compounds, pharmaceutical compositions thereof and therapeutic uses thereof 耶路撒冷希伯来大学伊萨姆研究发展公司 2020-11-20 CN claimed
US-10815222-B2 Compounds for use in the treatment of kinetoplastid infection C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) 2020-10-27 US claimed
US-20200095232-A1 COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION C.N.C.C.S. S.C.A.R.L. COLLEZIONE NAZIONALE DEI COMPOSTI CHIMICI E CENTRO SCREENING (IT) 2020-03-26 US claimed
EP-3558980-A1 COMPOUNDS FOR USE IN THE TREATMENT OF KINETOPLASTID INFECTION C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening (IT) 2019-10-30 EP claimed
WO-2019155468-A1 HETEROARYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC USE YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2019-08-15 WO claimed
CN-110087466-A ACTIVE COMPOUND COMBINATIONS 拜耳作物科学股份公司 2019-08-02 CN claimed
CN-110072390-A Use the method for carboxamides derivatives prevention and treatment bacterial diseases of plants 拜耳作物科学股份公司 2019-07-30 CN claimed
CN-105593214-B Method for synthesizing N-benzyl-N-cyclopropyl-1H-pyrazole-4-formamide derivative 拜耳作物科学股份公司 2018-05-29 CN claimed
CN-106962403-A Include biocontrol agent and insecticide composition 拜耳作物科学股份公司 2017-07-21 CN claimed
CN-104363758-B Compositions comprising biological control agents and pesticides 拜耳作物科学公司 2017-02-08 CN claimed
EP-2086944-A1 PROCESS FOR PREPARING DIFLUOROMETHYLPYRAZOLYL CARBOXYLATES BASF SE (DE) 2009-08-12 EP claimed
WO-2008053043-A1 PROCESS FOR PREPARING DIFLUOROMETHYLPYRAZOLYL CARBOXYLATES BASF SE (DE) 2008-05-08 WO claimed
US-6967197-B2 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-11-22 US claimed
US-20030134849-A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-17 US claimed
WO-2003018019-A2 NEW USE OF CYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-06 WO claimed
EP-1259499-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-27 EP claimed
WO-2001060808-A1 THIAZEPINYL HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-08-23 WO claimed